Responses
Regular and Young Investigator Award Abstracts
Combination Immunotherapies
788 Improved immunologic and therapeutic activity of anchored interleukin (IL-12) immunotherapy in combination with cytotoxic chemotherapy and immune checkpoint inhibitor in a head and neck cancer model
Compose a Response to This Article
Other responses
No responses have been published for this article.
